Oncology Data Advisor
The Groundbreaking Approval of Tebentafusp for Uveal Melanoma With Richard Carvajal, MD
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:05:15
- Mas informaciones
Informações:
Sinopsis
In this interview, Dr. Richard Carvajal, Associate Professor of Medicine at Columbia University Irving Medical Center and editorial board member of Oncology Data Advisor, discusses the practice-changing significance of the approval of tebentafusp and delves further into future directions in the development of treatments for uveal melanoma.
